Olmepas

Olmepas

olmesartan

Manufacturer:

Saga Lifesciences

Distributor:

Hexagon Pharma
Concise Prescribing Info
Contents
Olmesartan medoxomil
Indications/Uses
Dosage/Direction for Use
Initially 10 mg once daily. If BP is not controlled, may be increased to 20 mg once daily as an optimal dose & may be increased to 40 mg once daily if required.
Administration
May be taken with or without food.
Contraindications
Special Precautions
Patients w/ renal artery stenosis. Hypotension in patients w/ vol depletion. Monitor serum K conc. Avoid K-sparing diuretics. Renal & hepatic impairment. Not recommended during pregnancy (1st trimester) & lactation. Elderly.
Adverse Reactions
Dizziness, headache, & dose-related orthostatic hypotension. Impaired renal function; hyperkalemia, myalgia, & arthralgia; resp tract disorders, back pain, GI disturbances, fatigue & neutropenia.
Drug Interactions
May potentiate antihypertensive effect by drugs or other agents that lower BP. Additive hyperkalemic effect w/ K supplements, K-sparing diuretics, or other drugs that can cause hyperkalemia. Increased risk of renal impairment & may also attenuate hypotensive effect w/ NSAIDs.
MIMS Class
Angiotensin II Antagonists
ATC Classification
C09CA08 - olmesartan medoxomil ; Belongs to the class of angiotensin II receptor blockers (ARBs). Used in the treatment of cardiovascular disease.
Presentation/Packing
Form
Olmepas FC tab 20 mg
Packing/Price
30's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in